4,356 results found

Amendments to the TSX Company Manual have been adopted to extend the current exemption from security holder approval.

Joining Mario is Shez Bandukwala, Managing Director of KPMG's Corporate Finance Group in Toronto. Shez recently brought his 30-years of investment banking experience to the Canadian private equity market.

On June 29th, Howard Levitt was interviewed on Newstalk 1010's "The Night Side with Barb DiGiulio" discussing various caller employment dismissal scenarios...

Uncertainty lingered at the outset of 2016 in Canada from a slowdown in activity that began in the previous year

In the Canadian market, SunGard provisions have become more prevalent in commitment letters for large Canadian acquisition financings in the last few years.

Deficits in defined benefit pension plans will continue to be an issue in 2013.

En 2023, le milieu juridique et des affaires s'est considérablement transformé. Pour vous aider à mieux comprendre les derniers développements...

PolicyMe, a Canadian digital insurance provider, recently announced the successful close of C$30 million in new funding, building off of its C$3.3 million Seed Round (2020) and C$18 million Series A round (2022).

In this series of blogs, we will explore some key legal considerations and reviews key developments in Canada during 2021 and reflects on their significance for 2022 and beyond.

Numerous recent proceedings by the U.S. Federal Trade Commission and Department of Justice have made antitrust issues top of mind for U.S. private equity (PE).

On December 5, 2013, the Competition Bureau issued a No-Action Letter clearing Thermo Fisher Scientific Inc.’s proposed acquisition of Life Technologies Corporation.

The draft timing agreement is open for public comment until August 30.

Superior Plus Corp. abandoned plans to buy rival chemical manufacturer Canexus Corporation after the US Federal Trade Commission challenged the merger.

Amendments to the Competition Act that expand the affiliation rules came into force on May 1, 2018. Whereas rules for control ...

On December 14, the Competition Bureau entered into a consent agreement with McKesson Corporation in relation to its acquisition of Rexall Health from Katz Group.

Parties who fail to do so may find themselves involved in an unexpected Bureau review of their proposed or completed merger.

A key aspect of Canada’s consent procedure for settling matters with the Commissioner of Competition before the Competition Tribunal has come under attack.